Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis.
Miyazaki N, Iwasaki T, Sakai H, Watanuki R, Tanizawa Y, Cai Z, Kawaguchi T, Tsurutani J, Nagashima K. Miyazaki N, et al. Among authors: tanizawa y. Curr Med Res Opin. 2024 May;40(5):827-837. doi: 10.1080/03007995.2024.2332436. Epub 2024 Apr 10. Curr Med Res Opin. 2024. PMID: 38597173 Review.
Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database.
Shinozaki E, Makiyama A, Kagawa Y, Satake H, Tanizawa Y, Cai Z, Piao Y. Shinozaki E, et al. Among authors: tanizawa y. PLoS One. 2021 Feb 8;16(2):e0246160. doi: 10.1371/journal.pone.0246160. eCollection 2021. PLoS One. 2021. PMID: 33556095 Free PMC article.
Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer.
Satake H, Kagawa Y, Shinozaki E, Tanizawa Y, Jin L, Cai Z, Makiyama A. Satake H, et al. Among authors: tanizawa y. Adv Ther. 2022 Jun;39(6):2596-2613. doi: 10.1007/s12325-022-02122-4. Epub 2022 Apr 6. Adv Ther. 2022. PMID: 35384550 Free PMC article.
Association of Albumin-Bilirubin Grade and Sequential Treatment with Standard Systemic Therapies for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study Using a Japanese Administrative Database.
Hiraoka A, Tanizawa Y, Huang YJ, Cai Z, Sakaguchi S. Hiraoka A, et al. Among authors: tanizawa y. Drugs Real World Outcomes. 2021 Sep;8(3):301-314. doi: 10.1007/s40801-021-00245-8. Epub 2021 Apr 1. Drugs Real World Outcomes. 2021. PMID: 33792850 Free PMC article.
395 results